Search for: "Mylan Pharmaceutical Industries, Ltd." Results 1 - 20 of 89
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Teva Sues Mylan Over Multiple Sclerosis Drug COPAXONE ®
18 Oct 2009, 5:42 pm
Teva Pharmaceutical Industries Ltd. issued a press release last week discussing the abbreviated new drug application (ANDA) containing a Paragraph IV certification for COPAXONE ® (glatiramer acetate injection), filed by Mylan Pharmaceuticals Inc. [read post]
IPWatchdog.com | Patent Copyright Trademark - http://www.ipwatchdog.com
Court Report
13 Oct 2014, 8:46 pm by Patent Docs
• Defendants: Mylan Pharmaceuticals Inc.; Mylan Inc.; Natco Pharma Ltd. [read post]
Patent Docs - http://www.patentdocs.org/
Twenty States Join Forces Against Generic Drug Price-Fixing
6 Mar 2017, 9:00 am by Brianna Smith
From Mylan and their Epipen fiasco to Teva Pharmaceutical Industries Ltd, consumers are wondering when someone will step in to make this price gouging stop before drugs like the Epipen simply become unaffordable. [read post]
The Legal Reader - http://legalreader.com/
Teva suit against generic Momenta over Copaxone proceeds in SDNY
30 Aug 2011, 5:18 am by Lawrence B. Ebert
The Mylan case is Teva Pharmaceuticals Industries Ltd. v. [read post]
IPBiz - http://ipbiz.blogspot.com/
FTC Says Brand Name Drug Redesign Violates Antitrust Law
30 Nov 2012, 6:00 am by Gene Quinn
Teva Sues Mylan Over Multiple Sclerosis Drug COPAXONE®Teva Pharmaceutical Industries Ltd. issued a press release last week discussing the abbreviated new drug application (ANDA) containing a Paragraph IV certification for COPAXONE® (glatiramer acetate injection), filed by Mylan Pharmaceuticals Inc. [read post]
IPWatchdog.com | Patent Copyright Trademark - http://www.ipwatchdog.com
FTC Says Brand Name Drug Redesign Violates Antitrust Law
30 Nov 2012, 6:00 am by Gene Quinn
Teva Sues Mylan Over Multiple Sclerosis Drug COPAXONE®Teva Pharmaceutical Industries Ltd. issued a press release last week discussing the abbreviated new drug application (ANDA) containing a Paragraph IV certification for COPAXONE® (glatiramer acetate injection), filed by Mylan Pharmaceuticals Inc. [read post]
IPWatchdog.com | Patent Copyright Trademark - http://www.ipwatchdog.com
Indiana Patent Infringement Litigation: Eli Lilly Sues Numerous Defendants
17 Mar 2014, 11:03 am
Reddy's Laboratories, Inc.; Glenmark Generics Inc., USA; Glenmark Generics Ltd.; Glenmark Pharmaceuticals Ltd.; Hetero USA Inc.; Hetero Labs Limited; Hetero Labs Limited Unit V; Hetero Drugs Ltd.; Mylan Pharmaceuticals Inc.; Mylan Inc.; Mylan Laboratories Limited (these three companies are, collectively, "Mylan"); Par Pharmaceutical Companies, Inc.; Par Pharmaceutical, Inc.; Sun Pharma Global FZE;… [read post]
Indiana Intellectual Property Lawyer Blog - http://www.iniplaw.org/
New District of Delaware Intellectual Property Case Filings
18 Dec 2009, 9:59 am by Karen E. Keller
Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd. [read post]
Delaware IP Law Blog - http://www.delawareiplaw.com/
Santarus v. Par Pharmaceutical: Rader and Newman Disagree on Written Description Support for Negative Limitations
11 Sep 2012, 5:30 am by Gene Quinn
Teva Sues Mylan Over Multiple Sclerosis Drug COPAXONE®Teva Pharmaceutical Industries Ltd. issued a press release last week discussing the abbreviated new drug application (ANDA) containing a Paragraph IV certification for COPAXONE® (glatiramer acetate injection), filed by Mylan Pharmaceuticals Inc. [read post]
IPWatchdog.com | Patent Copyright Trademark - http://www.ipwatchdog.com
A Primer on Paragraph IV Certifications: Into the Belly of the Hatch-Waxman Beast Part 1
3 Apr 2013, 4:45 am by Eric Guttag
Teva Sues Mylan Over Multiple Sclerosis Drug COPAXONE®Teva Pharmaceutical Industries Ltd. issued a press release last week discussing the abbreviated new drug application (ANDA) containing a Paragraph IV certification for COPAXONE® (glatiramer acetate injection), filed by Mylan Pharmaceuticals Inc. [read post]
IPWatchdog.com | Patent Copyright Trademark - http://www.ipwatchdog.com
Indiana Patent Litigation - Lilly Adds Panacea Biotec to List of Patent Infringement Defendants
30 Jun 2014, 10:28 am
Reddy's Laboratories, Inc.; Glenmark Generics Inc., USA; Glenmark Generics Ltd.; Glenmark Pharmaceuticals Ltd.; Hetero USA Inc.; Hetero Labs Limited; Hetero Labs Limited Unit V; Hetero Drugs Ltd.; Mylan Pharmaceuticals Inc.; Mylan Inc.; Mylan Laboratories Limited; Par Pharmaceutical Companies, Inc.; Par Pharmaceutical, Inc.; Sun Pharma Global FZE; Caraco Pharmaceutical Laboratories, Ltd.;… [read post]
Indiana Intellectual Property Lawyer Blog - http://www.iniplaw.org/
Indiana Patent Litigation: Lilly Brings Another Defendant into Effient Patent Infringement Litigation
17 Jul 2014, 10:58 am
Reddy's Laboratories, Inc.; Glenmark Generics Inc., USA; Glenmark Generics Ltd.; Glenmark Pharmaceuticals Ltd.; Hetero USA Inc.; Hetero Labs Limited; Hetero Labs Limited Unit V; Hetero Drugs Ltd.; Mylan Pharmaceuticals Inc.; Mylan Inc.; Mylan Laboratories Limited; Par Pharmaceutical Companies, Inc.; Par Pharmaceutical, Inc.; Sun Pharma Global FZE; Caraco Pharmaceutical Laboratories, Ltd.;… [read post]
Indiana Intellectual Property Lawyer Blog - http://www.iniplaw.org/
The Dutch Poison Pill: How is it Different from an American Rights Plan?
1 Dec 2015, 6:20 am
”) to ward off an unsolicited takeover bid by the Israeli pharmaceutical company Teva Pharmaceutical Industries Ltd. [read post]
The Harvard Law School Corporate Governance Blog - http://blogs.law.harvard.edu/corpgov
Teva Recalls US-Made Drugs Following Contamination Fears
13 Dec 2021, 6:50 am by Robert Kraft
The Pittsburgh Post-Gazette reports, “Teva Pharmaceutical Industries Ltd., one of the largest generic drugmakers in the world, has recalled more than 2.5 million vials of drugs that the company said may not be sterile. [read post]
Kraft Elder Law Blog - http://www.kraftelderlaw.com/blog/
Pharmaceutical Manufacturers Pursued for Medicaid Fraud by Texas Attorney General's Office
26 Jun 2007, 10:48 pm
Ivax Pharmaceuticals Inc., Sicor Pharmaceuticals Inc., Teva Novopharm Inc. and Teva Pharmaceutical Industries, Ltd.). [read post]
Whistleblower Lawyer Blog - http://www.whistleblowerlawyerblog.com/
Later evidence may be relied on in patent validity disputes -- but only just
30 Jul 2013, 2:53 pm
One such case is Generics [UK] Ltd (t/a Mylan) v Yeda Research And Development Co Ltd and Teva Pharmaceutical Industries Ltd [2013] EWCA Civ 925, decided yesterday by a three-man Court of Appeal for England and Wales which consisted of two specialist IP judges -- Lords Justices Kitchin and Floyd -- together with Lord Justice Moses. [read post]
IPKat - http://ipkitten.blogspot.com/
New District of Delaware Intellectual Property Case Filings
1 Dec 2009, 9:45 am by Karen E. Keller
Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd. [read post]
Delaware IP Law Blog - http://www.delawareiplaw.com/
Neurim and Flynn v Mylan – Who is the real winner?
24 Mar 2021, 3:09 am by Olivia Henry (Bristows) and Claire Phipps-Jones (Bristows)
  This follows his 4 December 2020 judgment in Neurim Pharmaceuticals (1991) Limited & Flynn Pharma Limited v Generics UK Limited (t/a Mylan) & Mylan UK Healthcare Limited [2020] EWHC 3270 (Pat) (the “Judgment”). [read post]
Kluwer Patent Blog - http://patentblog.kluweriplaw.com/
New District of Delaware Intellectual Property Case Filings
28 Aug 2009, 8:11 am
Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Inc., Sun Pharma Global FZE, Caraco Pharmaceutical Laboratories Ltd. [read post]
Delaware IP Law Blog - http://www.delawareiplaw.com/
New District of Delaware Intellectual Property Case Filings
17 Feb 2010, 8:00 am by Karen E. Keller
Mylan Pharmaceuticals Inc. [read post]
Delaware IP Law Blog - http://www.delawareiplaw.com/